Interventional procedure overview of vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions
Closed for comments This consultation ended on at Request commenting lead permission
Table 1 Abbreviations
Abbreviation | Definition |
|---|---|
CCT | Controlled clinical trials |
CD | Clavien-Dindo (for example, CD-1 = Clavien-Dindo grade 1) |
DVT | Deep venous thrombosis |
EQ-5D-3L | EuroQol five-dimension three-level patient-reported outcome measure |
NR | Not reported |
PID | Pelvic inflammatory disease |
QoL | Quality of life |
RCT | Randomised controlled trials |
RoB2 | Risk of bias 2 |
ROBINS-I | Risk of bias in non-randomised studies |
SE | Standard error |
TLH | Total laparoscopic hysterectomy |
TU-LESS | Transumbilical laparoendoscopic single-site surgery |
VAS | Visual analogue scale |
vNOTES | Transvaginal natural orifice transluminal endoscopic surgery |
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions